Your browser doesn't support javascript.
loading
Impact and cost-effectiveness of SARS-CoV-2 self-testing strategies in schools: a multicountry modelling analysis.
Chevalier, Joshua M; Han, Alvin X; Hansen, Megan A; Klock, Ethan; Pandithakoralage, Hiromi; Ockhuisen, Tom; Girdwood, Sarah J; Lekodeba, Nkgomeleng A; de Nooy, Alexandra; Khan, Shaukat; Johnson, Cheryl C; Sacks, Jilian A; Jenkins, Helen E; Russell, Colin A; Nichols, Brooke E.
Afiliação
  • Chevalier JM; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Han AX; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Hansen MA; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Klock E; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Pandithakoralage H; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Ockhuisen T; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Girdwood SJ; FIND, Geneva, Switzerland.
  • Lekodeba NA; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • de Nooy A; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Khan S; FIND, Geneva, Switzerland.
  • Johnson CC; HIV Department, World Health Organization, Geneva, Switzerland.
  • Sacks JA; Department of Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland.
  • Jenkins HE; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Russell CA; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Nichols BE; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands brooke.nichols@finddx.org.
BMJ Open ; 14(2): e078674, 2024 Feb 27.
Article em En | MEDLINE | ID: mdl-38417953
ABSTRACT

OBJECTIVES:

To determine the most epidemiologically effective and cost-effective school-based SARS-CoV-2 antigen-detection rapid diagnostic test (Ag-RDT) self-testing strategies among teachers and students.

DESIGN:

Mathematical modelling and economic evaluation. SETTING AND

PARTICIPANTS:

Simulated school and community populations were parameterised to Brazil, Georgia and Zambia, with SARS-CoV-2 self-testing strategies targeted to teachers and students in primary and secondary schools under varying epidemic conditions.

INTERVENTIONS:

SARS-CoV-2 Ag-RDT self-testing strategies for only teachers or teachers and students-only symptomatically or symptomatically and asymptomatically at 5%, 10%, 40% or 100% of schools at varying frequencies. OUTCOME

MEASURES:

Outcomes were assessed in terms of total infections and symptomatic days among teachers and students, as well as total infections and deaths within the community under the intervention compared with baseline. The incremental cost-effectiveness ratios (ICERs) were calculated for infections prevented among teachers and students.

RESULTS:

With respect to both the reduction in infections and total cost, symptomatic testing of all teachers and students appears to be the most cost-effective strategy. Symptomatic testing can prevent up to 69·3%, 64·5% and 75·5% of school infections in Brazil, Georgia and Zambia, respectively, depending on the epidemic conditions, with additional reductions in community infections. ICERs for symptomatic testing range from US$2 to US$19 per additional school infection averted as compared with symptomatic testing of teachers alone.

CONCLUSIONS:

Symptomatic testing of teachers and students has the potential to cost-effectively reduce a substantial number of school and community infections.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article